Sublingual Immunotherapy – An Alternative to Allergy Shots Whose Time Has Come
JAMA march 27th 2013 article “Sublingual Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and Asthma“, is a review of 63 studies on this topic.
Since allergic rhinitis affects up to 40% of the US population, and asthma affects over 5% of the population, as well as being responsible for over 500,000 hospitalizations and over 5000 deaths each year, proper desensitization to what you are allergic to can have a huge health benefit. In the US, this has typically meant allergy shots at the allergist. In Europe, 45% of immunotherapy is done sublingual (under the tongue), and in Southern Europe, 80% is done this way. This study supports that sublingual immunotherapy results in a greater than 40% improvement in asthma and allergy symptoms.
The good news for my patients at Integrative Pediatrics is that we have been using sublingual Immunotherpay (SLIT) for over two years, with no adverse outcomes and very good results. If your child has asthma or severe allergy symptoms (runny nose and itchy eyes) that interfere with life’s activities, we can assess allergies with a simple blood test (Immunocap – IGE test) and then, if needed, devise a program for your child over age 5 using SLIT.